<?xml version="1.0" encoding="utf-8"?>
<feed xmlns="http://www.w3.org/2005/Atom">
<title>Legal Insider Trading Data | Free and Professional Subscription Services | Insider Insights</title>
<link href="http://www.insiderinsights.com/news/company/rapp" ></link>
<id>urn:uuid:cc4b7e67-26c3-2fa0-15f4-81882c7a739e</id>
<updated>2026-10-31T14:33:21-04:00</updated>
<author>Jonathan Moreland</author>
<subtitle>Profit from legal insider trading. InsiderInsights.com provides free insider trading data tools and resources, and professional grade subscription based real time Form 4 data, analysis and services</subtitle>
<entry>
<title>RAPP: HEALY JAMES (DIR) Bought (JB*) 969,480 Shares of RAPPORT THERAPEUTICS INC for $21.00 on 10/28</title>
<link href="http://www.insiderinsights.com/company/rapp/rapport-therapeutics-inc/id-6485590" ></link>
<id>urn:uuid:4238ee9e-ad2d-e581-1d8e-e38e60d4f27e</id>
<updated>2026-10-30T19:32:45-04:00</updated>
<summary type="html" ><![CDATA[RAPPORT THERAPEUTICS INC (RAPP). Recent Price: $25.05. Mkt Cap:1.2B. 10D Vol: 2.5mm]]></summary>
</entry>
<entry>
<title>RAPP: CEESAY ABRAHAM (CEO,DIR) Sold (AS) 2,210 Shares of RAPPORT THERAPEUTICS INC for $29.16 on 10/21</title>
<link href="http://www.insiderinsights.com/company/rapp/rapport-therapeutics-inc/id-6483606" ></link>
<id>urn:uuid:12c5f467-0277-efe4-bd0c-7a9cbd4376d3</id>
<updated>2026-10-23T16:30:06-04:00</updated>
<summary type="html" ><![CDATA[RAPPORT THERAPEUTICS INC (RAPP). Recent Price: $25.05. Mkt Cap:1.2B. 10D Vol: 2.5mm]]></summary>
</entry>
<entry>
<title>RAPP: SANCHEZ RAMIRO (DIR) Bought (B) 3,600 Shares of RAPPORT THERAPEUTICS INC for $27.35 on 10/23</title>
<link href="http://www.insiderinsights.com/company/rapp/rapport-therapeutics-inc/id-6483531" ></link>
<id>urn:uuid:3f8977a1-1a27-09e3-00a3-6563b0002a30</id>
<updated>2026-10-23T16:01:03-04:00</updated>
<summary type="html" ><![CDATA[RAPPORT THERAPEUTICS INC (RAPP). Recent Price: $25.05. Mkt Cap:1.2B. 10D Vol: 2.5mm]]></summary>
</entry>
<entry>
<title>RAPP: SILVA PAUL M (DIR) Bought (B) 3,680 Shares of RAPPORT THERAPEUTICS INC for $27.07 on 10/22</title>
<link href="http://www.insiderinsights.com/company/rapp/rapport-therapeutics-inc/id-6483360" ></link>
<id>urn:uuid:5507e846-b5b9-f600-de29-708373a73f50</id>
<updated>2026-10-22T16:57:07-04:00</updated>
<summary type="html" ><![CDATA[RAPPORT THERAPEUTICS INC (RAPP). Recent Price: $25.05. Mkt Cap:1.2B. 10D Vol: 2.5mm]]></summary>
</entry>
<entry>
<title>RAPP: YOUNG WENDY B (DIR) Bought (B) 3,789 Shares of RAPPORT THERAPEUTICS INC for $26.39 on 10/22</title>
<link href="http://www.insiderinsights.com/company/rapp/rapport-therapeutics-inc/id-6483361" ></link>
<id>urn:uuid:fe73267f-8bd4-684a-29fa-4cf2b530f92e</id>
<updated>2026-10-22T16:56:54-04:00</updated>
<summary type="html" ><![CDATA[RAPPORT THERAPEUTICS INC (RAPP). Recent Price: $25.05. Mkt Cap:1.2B. 10D Vol: 2.5mm]]></summary>
</entry>
<entry>
<title>RAPP: PAUL STEVEN M (DIR) Bought (B) 35,714 Shares of RAPPORT THERAPEUTICS INC for $27.28 on 10/22</title>
<link href="http://www.insiderinsights.com/company/rapp/rapport-therapeutics-inc/id-6483362" ></link>
<id>urn:uuid:bd7d80d9-c535-9207-0957-eef17d11a071</id>
<updated>2026-10-22T16:56:38-04:00</updated>
<summary type="html" ><![CDATA[RAPPORT THERAPEUTICS INC (RAPP). Recent Price: $25.05. Mkt Cap:1.2B. 10D Vol: 2.5mm]]></summary>
</entry>
<entry>
<title>RAPP: MARAGANORE JOHN (DIR) Bought (B) 1,172 Shares of RAPPORT THERAPEUTICS INC for $26.92 on 10/22</title>
<link href="http://www.insiderinsights.com/company/rapp/rapport-therapeutics-inc/id-6483357" ></link>
<id>urn:uuid:aba0e7c9-8e3c-eb26-d186-9869b3aaf99c</id>
<updated>2026-10-22T16:56:25-04:00</updated>
<summary type="html" ><![CDATA[RAPPORT THERAPEUTICS INC (RAPP). Recent Price: $25.05. Mkt Cap:1.2B. 10D Vol: 2.5mm]]></summary>
</entry>
<entry>
<title>RAPP: MARAGANORE JOHN (DIR) Bought (B) 8,239 Shares of RAPPORT THERAPEUTICS INC for $26.38 on 10/22</title>
<link href="http://www.insiderinsights.com/company/rapp/rapport-therapeutics-inc/id-6483358" ></link>
<id>urn:uuid:a1a0f0b6-d136-9280-9b7e-0b50b6ae7344</id>
<updated>2026-10-22T16:56:25-04:00</updated>
<summary type="html" ><![CDATA[RAPPORT THERAPEUTICS INC (RAPP). Recent Price: $25.05. Mkt Cap:1.2B. 10D Vol: 2.5mm]]></summary>
</entry>
<entry>
<title>RAPP: IGNELZI TROY A (CFO) Bought (B) 5,500 Shares of RAPPORT THERAPEUTICS INC for $26.10 on 10/21</title>
<link href="http://www.insiderinsights.com/company/rapp/rapport-therapeutics-inc/id-6483136" ></link>
<id>urn:uuid:d6e348a3-64bc-7d95-7836-016e45337ecc</id>
<updated>2026-10-21T17:46:54-04:00</updated>
<summary type="html" ><![CDATA[RAPPORT THERAPEUTICS INC (RAPP). Recent Price: $25.05. Mkt Cap:1.2B. 10D Vol: 2.5mm]]></summary>
</entry>
<entry>
<title>RAPP: CEESAY ABRAHAM (CEO,DIR) Sold (AS) 4,522 Shares of RAPPORT THERAPEUTICS INC for $30.66 on 10/6-10/7</title>
<link href="http://www.insiderinsights.com/company/rapp/rapport-therapeutics-inc/id-6479412" ></link>
<id>urn:uuid:884e667d-2633-2d9b-f9b1-3cdcac7035e4</id>
<updated>2026-10-08T16:07:04-04:00</updated>
<summary type="html" ><![CDATA[RAPPORT THERAPEUTICS INC (RAPP). Recent Price: $25.05. Mkt Cap:1.2B. 10D Vol: 2.5mm]]></summary>
</entry>
</feed>